Protect Pharmaceutical Corporation
PRTT · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $59,749 | $81,006 | $32,517 | $68,941 |
| - Cash | $20,047 | $19,073 | $17,664 | $9,622 |
| + Debt | $4,405 | $4,175 | $3,830 | $3,861 |
| Enterprise Value | $44,107 | $66,108 | $18,683 | $63,180 |
| Revenue | $26,336 | $25,662 | $29,732 | $30,657 |
| % Growth | 2.6% | -13.7% | -3% | – |
| Gross Profit | $14,669 | $14,392 | $16,023 | $21,905 |
| % Margin | 55.7% | 56.1% | 53.9% | 71.5% |
| EBITDA | $8,838 | $8,751 | $10,257 | $21,872 |
| % Margin | 33.6% | 34.1% | 34.5% | 71.3% |
| Net Income | $6,629 | $6,563 | $10,057 | $26,093 |
| % Margin | 25.2% | 25.6% | 33.8% | 85.1% |
| EPS Diluted | 0.12 | 0.11 | 0.18 | 0.45 |
| % Growth | 9.1% | -38.9% | -60% | – |
| Operating Cash Flow | -$2,099 | $2,430 | $6,311 | -$464 |
| Capital Expenditures | -$2,471 | -$510 | -$510 | $0 |
| Free Cash Flow | -$4,570 | $1,920 | $5,801 | -$464 |